Based on the Surgery Partners Inc stock forecast from 10 analysts, the average analyst target price for Surgery Partners Inc is USD 32.69 over the next 12 months. Surgery Partners Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Surgery Partners Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Surgery Partners Inc’s stock price was USD 20.51. Surgery Partners Inc’s stock price has changed by -13.64% over the past week, -14.72% over the past month and -25.01% over the last year.
No recent analyst target price found for Surgery Partners Inc
No recent average analyst rating found for Surgery Partners Inc
Company Overview Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Read Less
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various s...Read More
Frequently Asked Questions About Surgery Partners Inc (SGRY) Stock
Based on ratings from 10 analysts Surgery Partners Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on SGRY's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for SGRY is USD 32.69 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 28.
SGRY stock's Price/Earning ratio is 3,124.00.
Our analysis grades SGRY stock's Price / Earning ratio at F. This means that SGRY stock's Price/Earning ratio is above 94% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this SGRY may be a overvalued for its sector.
The last closing price of SGRY's stock was USD 20.51.
The most recent market capitalization for SGRY is USD 2.69B.
Based on targets from 10 analysts, the average taret price for SGRY is projected at USD 32.69 over the next 12 months.
This means that SGRY's stock price may go up by +59.24% over the next 12 months.
We can't find any ETFs which contains Surgery Partners Inc's stock.
As per our most recent records Surgery Partners Inc has 15,000 Employees.
Surgery Partners Inc's registered address is 340 Seven Springs Way, Brentwood, TN, United States, 37027.
You can get more information about it from Surgery Partners Inc's website at https://www.surgerypartners.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Surgery Partners Inc (SGRY) Stock
Based on ratings from 10 analysts Surgery Partners Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on SGRY's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for SGRY is USD 32.69 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 28.
SGRY stock's Price/Earning ratio is 3,124.00.
Our analysis grades SGRY stock's Price / Earning ratio at F. This means that SGRY stock's Price/Earning ratio is above 94% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this SGRY may be a overvalued for its sector.
The last closing price of SGRY's stock was USD 20.51.
The most recent market capitalization for SGRY is USD 2.69B.
Based on targets from 10 analysts, the average taret price for SGRY is projected at USD 32.69 over the next 12 months.
This means that SGRY's stock price may go up by +59.24% over the next 12 months.
We can't find any ETFs which contains Surgery Partners Inc's stock.
As per our most recent records Surgery Partners Inc has 15,000 Employees.
Surgery Partners Inc's registered address is 340 Seven Springs Way, Brentwood, TN, United States, 37027.
You can get more information about it from Surgery Partners Inc's website at https://www.surgerypartners.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SGRY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
